BioNTech Delivers Blowout Q1 Results

BioNTech (NASDAQ: BNTX) is on a roll. The company, along with its big partner Pfizer (NYSE: PFE), has reported a plethora of positive news in recent months for their COVID-19 vaccine, BNT162b2. And now BioNTech has more good news to add.

The German drugmaker announced its first-quarter results before the market opened on Monday. Investors liked what they heard, and the biotech stock jumped 9% in pre-market trading. Here are the highlights from BioNTech's Q1 update.

Image source: Getty Images.

Continue reading

Source Fool.com